Copyright Reports & Markets. All rights reserved.

Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 SSRI
      • 1.4.3 TCA
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Obsessive-Compulsive Disorder Drugs Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Research Institute
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Obsessive-Compulsive Disorder Drugs Market Size
    • 2.2 Obsessive-Compulsive Disorder Drugs Growth Trends by Regions
      • 2.2.1 Obsessive-Compulsive Disorder Drugs Market Size by Regions (2019-2025)
      • 2.2.2 Obsessive-Compulsive Disorder Drugs Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Obsessive-Compulsive Disorder Drugs Market Size by by Players
      • 3.1.1 Global Obsessive-Compulsive Disorder Drugs Revenue by by Players (2014-2019)
      • 3.1.2 Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Obsessive-Compulsive Disorder Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Obsessive-Compulsive Disorder Drugs Key Players Head office and Area Served
    • 3.3 Key Players Obsessive-Compulsive Disorder Drugs Product/Solution/Service
    • 3.4 Date of Enter into Obsessive-Compulsive Disorder Drugs Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Obsessive-Compulsive Disorder Drugs Market Size by Type (2014-2019)
    • 4.2 Global Obsessive-Compulsive Disorder Drugs Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Obsessive-Compulsive Disorder Drugs Market Size (2014-2019)
    • 5.2 Obsessive-Compulsive Disorder Drugs Key Players in North America
    • 5.3 North America Obsessive-Compulsive Disorder Drugs Market Size by Type
    • 5.4 North America Obsessive-Compulsive Disorder Drugs Market Size by Application

    6 Europe

    • 6.1 Europe Obsessive-Compulsive Disorder Drugs Market Size (2014-2019)
    • 6.2 Obsessive-Compulsive Disorder Drugs Key Players in Europe
    • 6.3 Europe Obsessive-Compulsive Disorder Drugs Market Size by Type
    • 6.4 Europe Obsessive-Compulsive Disorder Drugs Market Size by Application

    7 China

    • 7.1 China Obsessive-Compulsive Disorder Drugs Market Size (2014-2019)
    • 7.2 Obsessive-Compulsive Disorder Drugs Key Players in China
    • 7.3 China Obsessive-Compulsive Disorder Drugs Market Size by Type
    • 7.4 China Obsessive-Compulsive Disorder Drugs Market Size by Application

    8 Japan

    • 8.1 Japan Obsessive-Compulsive Disorder Drugs Market Size (2014-2019)
    • 8.2 Obsessive-Compulsive Disorder Drugs Key Players in Japan
    • 8.3 Japan Obsessive-Compulsive Disorder Drugs Market Size by Type
    • 8.4 Japan Obsessive-Compulsive Disorder Drugs Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size (2014-2019)
    • 9.2 Obsessive-Compulsive Disorder Drugs Key Players in Southeast Asia
    • 9.3 Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size by Type
    • 9.4 Southeast Asia Obsessive-Compulsive Disorder Drugs Market Size by Application

    10 India

    • 10.1 India Obsessive-Compulsive Disorder Drugs Market Size (2014-2019)
    • 10.2 Obsessive-Compulsive Disorder Drugs Key Players in India
    • 10.3 India Obsessive-Compulsive Disorder Drugs Market Size by Type
    • 10.4 India Obsessive-Compulsive Disorder Drugs Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Obsessive-Compulsive Disorder Drugs Market Size (2014-2019)
    • 11.2 Obsessive-Compulsive Disorder Drugs Key Players in Central & South America
    • 11.3 Central & South America Obsessive-Compulsive Disorder Drugs Market Size by Type
    • 11.4 Central & South America Obsessive-Compulsive Disorder Drugs Market Size by Application

    12 International Players Profiles

    • 12.1 Eli Lilly and Co.
      • 12.1.1 Eli Lilly and Co. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Obsessive-Compulsive Disorder Drugs Introduction
      • 12.1.4 Eli Lilly and Co. Revenue in Obsessive-Compulsive Disorder Drugs Business (2014-2019))
      • 12.1.5 Eli Lilly and Co. Recent Development
    • 12.2 GlaxoSmithKline Plc
      • 12.2.1 GlaxoSmithKline Plc Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Obsessive-Compulsive Disorder Drugs Introduction
      • 12.2.4 GlaxoSmithKline Plc Revenue in Obsessive-Compulsive Disorder Drugs Business (2014-2019)
      • 12.2.5 GlaxoSmithKline Plc Recent Development
    • 12.3 H. Lundbeck AS
      • 12.3.1 H. Lundbeck AS Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Obsessive-Compulsive Disorder Drugs Introduction
      • 12.3.4 H. Lundbeck AS Revenue in Obsessive-Compulsive Disorder Drugs Business (2014-2019)
      • 12.3.5 H. Lundbeck AS Recent Development
    • 12.4 Novartis AG
      • 12.4.1 Novartis AG Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Obsessive-Compulsive Disorder Drugs Introduction
      • 12.4.4 Novartis AG Revenue in Obsessive-Compulsive Disorder Drugs Business (2014-2019)
      • 12.4.5 Novartis AG Recent Development
    • 12.5 Pfizer Inc.
      • 12.5.1 Pfizer Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Obsessive-Compulsive Disorder Drugs Introduction
      • 12.5.4 Pfizer Inc. Revenue in Obsessive-Compulsive Disorder Drugs Business (2014-2019)
      • 12.5.5 Pfizer Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Obsessive–compulsive disorder (OCD) is a mental disorder in which a person feels the need to perform certain routines repeatedly (called "compulsions"), or has certain thoughts repeatedly (called "obsessions").
      The launch of new molecules is one of the primary drivers for the obsessive-compulsive disorder drugs market growth. Conventional therapies used to treat the condition are only short-term treatment. The conventional anti-anxiety, antipsychotic, and antidepressant drugs are administered along with behavioral therapies and psychotherapy. The current long-term treatment involves the management of the condition, which requires patient compliance that has its drawbacks. Vendors are leveraging this situation and are focusing on the R&D of new drugs with improved bioavailability, pharmacology, safety, and dosage parameters. These new OCD drugs are currently being evaluated and will enroll soon by a series of new launches. As a result, the demand for these drugs will increase.
      In 2018, the global Obsessive-Compulsive Disorder Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Obsessive-Compulsive Disorder Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Obsessive-Compulsive Disorder Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Eli Lilly and Co.
      GlaxoSmithKline Plc
      H. Lundbeck AS
      Novartis AG
      Pfizer Inc.
      ...

      Market segment by Type, the product can be split into
      SSRI
      TCA
      Others

      Market segment by Application, split into
      Hospital
      Clinic
      Research Institute
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Obsessive-Compulsive Disorder Drugs status, future forecast, growth opportunity, key market and key players.
      To present the Obsessive-Compulsive Disorder Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Obsessive-Compulsive Disorder Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now